Fireside Chat: Biologics rising: India’s next scientific frontier

Panellists in this video: • Dr Vaibhav Dubey, AVP, Kashiv BioSciences (Moderator) • Dr Jaby Jacob, Sr President, R&D, BSV (A Mankind Group Company) • Dr Rakesh Kumar Sinha, Sr VP, Biological E Key Highlights: [1] Biologics is witnessing rapid growth, with increasing investments, technology advancement and knowledge creation driving the sector forward. [2] Biologics success requires patience and sustained investment, as development timelines are significantly longer than traditional small molecules. [3] Technology-led process innovation is critical to improve yields, reduce costs and make advanced therapies more affordable. [4] The next wave of innovation lies in emerging modalities such as cell therapies, gene therapies, siRNA, and mRNA-based treatments. [5] Strategic partnerships and in-licensing models help de-risk investments while accelerating capability building in biologics. The post Fireside Chat: Biologics rising: India’s next scientific frontier appeared first on Express Pharma.